American Diabetes Association recommendations on haemoglobin A1c use in diabetes diagnosis: time to include point-of-care devices?

Ann Clin Biochem. 2016 Sep;53(Pt 5):620. doi: 10.1177/0004563215619440. Epub 2016 Jan 20.

Authors

Seamus Sreenan¹, William Tormey²

Affiliations

¹ 3U Diabetes, Department of Diabetes and Endocrinology, Royal College of Surgeons in Ireland, Connolly Hospital, Dublin, Ireland seamus.sreenan@hse.ie.
² Department of Chemical Pathology, Connolly Hospital, Dublin and Biomedical Sciences, University of Ulster, Coleraine, Northern Ireland.

PMID: 26792778
DOI: 10.1177/0004563215619440

No abstract available

Publication types

Editorial

MeSH terms

Diabetes Mellitus / blood
Diabetes Mellitus / diagnosis*
Glycated Hemoglobin / metabolism*
Hemoglobinometry
Humans
Point-of-Care Systems
Practice Guidelines as Topic

Substances

Glycated Hemoglobin A
hemoglobin A1c protein, human